Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Farxiga granted FDA Priority Review for patients with heart failure with reduced ejection fraction
-
Lokelma approved in China for the treatment of adult patients with hyperkalaemia
-
template
-
Lynparza approved in the US as a 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer
-
AstraZeneca’s Mene Pangalos awarded knighthood in the New Year 2020 Honours List
-
AstraZeneca’s triple-combination therapy approved in China for patients with COPD
-
Enhertu (trastuzumab deruxtecan) approved in the US for HER2-positive unresectable or metastatic breast cancer following two or more prior anti-HER2 based regimens
-
AstraZeneca divests rights to Arimidex and Casodex in Europe and certain additional countries
-
Lynparza recommended by FDA advisory committee for 1st-line maintenance treatment of germline BRCA-mutated metastatic pancreatic cancer
-
Agreement with Cheplapharm for rights to Seroquel and Seroquel XR in Europe and Russia completed
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here